| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |